Search

CBS 60 Minutes covered superbugs this week. Buying colistin off the shelf, anyone?

A new paper (published today!) by Ann Gregory and colleagues shows identification of almost 200,000 new viral populations in the ocean (this work comes in part from the Tara Oceans expedition). The work identifies interesting new biodiversi

AmpliPhi just received positive FDA feedback for phase 2 clinical trials using their phage cocktails against Pseudomonas aeruginosa (AB-PA01) and Staphylococcus aureus (AB-SA01).

Phage Futures (January 29-30, 2019) is a translational phage therapy conference where Steffanie Strathdee, Tom Patterson, the FDA, and others will discuss how we move phage therapy forward in the US. Registration is open to all - use code “

Pherecydes published the long-awaited results of PhagoBurn, the first blinded, controlled, randomized phage trial on burn patients.

Steffanie Strathdee and Urmi S. Bajpai announced a new 12-month postdoc position starting July 2019. The postdoc will work on phages in Dr. Bajpai’s lab at ANDC in Delhi. Contact urmibajpai@andc.du.ac.in to apply (fellowship application dea

Congratulations to Jesca Nakavuma and her team of phage researchers in Uganda for winning an $800,000 grant from the African Union. The grant will support their development of phage products combating antibiotic resistant bacteria in fish.

A large group of leaders in the phage community and beyond has published a set of minimum standards that should be reported alongside any new, uncultivated viral sequence. If more of the community adopts these standards, it will be easier f

Justin Silpe and Bonnie Bassler discovered that a Vibrio cholerae phage senses its host’s quorum sensing molecules and lyses only when enough hosts are present in the surrounding area. By engineering this system, they got phages to lyse in

The American Society for Microbiology will host ASM Microbe 2019 in San Francisco June 20-24, and the abstract submission deadline is Jan. 15, 2019—submit yours here!

Did you know ASM has a phage group called Division M?. Members are invited to attend Division M's Business Meeting on June 21 at 5 PM (at ASM Microbe 2019) for food, drinks and (phage) conversation!

Mark your calendars for another exciting translational phage conference! The Bacteriophage Therapy Summit will take place in Boston, Massachusetts March 26-27, 2019. The meeting will focus on the discovery, translation and acceleration of p

Not one but TWO interesting new phage methods papers have just been published by KU Leuven researchers. The first, by Hanne Hendrix et al. details how to screen for growth-inhibitory proteins made by phages. The second, by Jeroen De Smet et

Phage Futures Congress (January 29-30, 2019) is fast-approaching! Speakers include representatives of the FDA (Scott Stibitz, Cara Fiore), biotech (Xavier Duportet, Carl Merril), academia (Martha Clokie, Betty Kutter, Steffanie Strathdee) a

The phage therapy biotech company Ampliphi Biosciences is merging with C3J Therapeutics, a synthetic phage/antimicrobial engineering company.

Adaptive Phage Therapeutics has partnered with Yale University to manufacture and supply phages for use in Yale's upcoming clinical trials.

Thanks to support from Roche Molecular Diagnostics and Intralytix, ASM Division M will provide 4 travel awards to students presenting phage work at ASM Microbe 2019! To apply, use "phage" as a keyword in your submitted abstract. Before you

Due to the partial U.S. government shutdown, ASM is extending the deadline for ASM Microbe abstract submissions to January 25, 2019.

A phase II clinical trial for a phage lysin has been deemed successful! An anti-Staphylococcus aureus phage lysin, called exebacase, was just found to be both safe and effective at treating MRSA in patients. Exebacase is being developed by

IPATH has just received FDA approval to start its first clinical trial! This will be the first US trial involving intravenous (IV) phage treatment, and will be a collaboration with Ampliphi Biosciences.